A five-hour modular series for physicians, nurse practitioners, physician assistants, nurse anesthetists and anesthesiologist assistants who prescribe or administer controlled substances — professionally narrated, faculty-led, and built to satisfy state opioid-CME mandates and the federal DEA (MATE Act) training expectation.
Most clinicians need two or three hours, not five — and the price is the same either way. Tell us where you're licensed and we'll show you your real obligation, whether this activity satisfies it, and how it gets reported. Fifteen seconds, no account.
Requirements are compiled from primary board sources and reviewed on a recurring schedule, but boards change rules. This is not legal advice — always verify with your board before relying on it.
One activity of record, five one-hour modules. Each is written to stand alone, so the hours you take are the hours you need.
The prescriber's dual accountability, the regulatory framework, the 2022 CDC guideline in practice, reading a PDMP report, and recognizing opioid use disorder without stigma.
1.0 creditStructured pain assessment, the twelve 2022 CDC recommendations, validated risk tools, opioid-sparing multimodal regimens, and the continue-versus-exit decision.
1.0 creditDSM-5-TR diagnosis and staging, the three FDA-approved medications, buprenorphine initiation including low-dose induction in the fentanyl era, and ASAM level-of-care decisions.
1.0 creditGeriatric, pregnancy and lactation, and pediatric prescribing; cancer and palliative pain principles; naloxone, fentanyl test strips, and harm reduction without stigma.
1.0 creditDEA schedules and registration, EPCS, mandatory PDMP queries and how to read the report, discordance conversations, and documentation that protects you in a board review.
1.0 creditProfessionally narrated slides with embedded on-camera faculty segments — engineered for a commute, a treadmill, or a desk.
Course Director & Faculty · Pediatric Hematology-Oncology
Dr. Shakeel and all planners and reviewers of this activity report no relevant financial relationships with ineligible companies.
Off-label disclosure
This activity discusses uses of medications that are not approved by the U.S. Food and Drug Administration for the indication described. Such uses are identified where they arise — on screen and in the narration — and reflect published clinical guidance, not FDA-approved labeling.
This activity is in final ACCME/PACE accreditation review. It has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME, for joint providership by Partners for Advancing Clinical Education and Interstate Medicine LLC. Upon accreditation, Partners for Advancing Clinical Education will designate this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™ per hour (up to 5.0 for the series). Credit cannot be claimed until accreditation is issued. Claim only credit commensurate with participation.
Once accreditation is issued, certificates would be issued per hour completed, for physicians (MD/DO), nurse practitioners, physician assistants, nurse anesthetists and anesthesiologist assistants. Completion of each hour, the post-test and the activity evaluation would be required before claiming credit.
Portions of this activity were developed with the assistance of artificial-intelligence tools under faculty direction and review.
One flat founding price for the whole activity — up to 5.0 AMA PRA Category 1 Credits™ once accreditation is issued. One email at launch, no spam.